טוען...

Cisplatin-induced haemolytic uraemic syndrome associated with a novel intronic mutation of CD46 treated with eculizumab

A 2-year-old patient with a neuroblastoma developed haemolytic uraemic syndrome (HUS) following treatment with cisplatin and carboplatin. Following treatment with eculizumab, there was a substantial improvement in renal function with the recovery of the platelet count and the cessation of haemolysis...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gilbert, Rodney D., Stanley, Louise K., Fowler, Darren J., Angus, Elizabeth M., Hardy, Steven A., Goodship, Timothy H.
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888095/
https://ncbi.nlm.nih.gov/pubmed/24422172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sft065
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!